Jerry S. Lanchbury

2019

In 2019, Jerry S. Lanchbury earned a total compensation of $2.7M as Chief Scientific Officer at Myriad Genetics, a 13% increase compared to previous year.

Compensation breakdown

Bonus$200
Non-Equity Incentive Plan$250,228
Salary$508,595
Stock Awards$1,914,000
Other$12,727
Total$2,685,750

Lanchbury received $1.9M in stock awards, accounting for 71% of the total pay in 2019.

Lanchbury also received $200 in bonus, $250.2K in non-equity incentive plan, $508.6K in salary and $12.7K in other compensation.

Rankings

In 2019, Jerry S. Lanchbury's compensation ranked 4,545th out of 13,971 executives tracked by ExecPay. In other words, Lanchbury earned more than 67.5% of executives.

ClassificationRankingPercentile
All
4,545
out of 13,971
68th
Division
Manufacturing
1,695
out of 5,692
70th
Major group
Chemicals And Allied Products
592
out of 2,189
73rd
Industry group
Drugs
498
out of 1,875
73rd
Industry
In Vitro and In Vivo Diagnostic Substances
11
out of 77
86th

Pay ratio

Jerry S. Lanchbury's Pay$2,685,750
Median Employee's Pay$77,814
Pay Ratio

35

to 1

In 2019, the annual total compensation of Jerry S. Lanchbury was $2,685,750.

The annual total compensation of the median employee at Myriad Genetics was $77,814.

The ratio of Jerry S. Lanchbury's pay to the pay of median employee was therefore 35 to one.

Source: SEC filing on October 16, 2019.

Lanchbury's colleagues

We found four more compensation records of executives who worked with Jerry S. Lanchbury at Myriad Genetics in 2019.

2019

Mark Capone

Myriad Genetics

Chief Executive Officer

2019

Alexander Ford

Myriad Genetics

President, Myriad Genetic Laboratories

2019

R Riggsbee

Myriad Genetics

Chief Financial Officer

2019

Richard Marsh

Myriad Genetics

General Counsel

News

You may also like